• Nenhum resultado encontrado

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.

N/A
N/A
Protected

Academic year: 2017

Share "Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial."

Copied!
9
0
0

Texto

Loading

Imagem

Figure 1. Patient flow chart. Consort Patient flow chart: AmBisomeH multi dose vs. single dose, ITT Intention to treat, PP per protocol, LTFU Lost to Follow-up.
Table 1. Baseline data on patient demographics, clinical characteristics and laboratory values.
Figure 3. Parasite clearance from peripheral blood. Comparison of parasite clearance rates from peripheral blood in single (10 mg/kg) and multiple dose (763 mg/kg) regimens of AmBisome H

Referências

Documentos relacionados

No estudo de revisão sistemática com Meta-Análise, que analisou a influência dos programas de treinamento aeróbio, de força e combinado na glicose sanguínea em

A randomised, double- blind, placebo-controlled, dose-raging study to compare the efficacy and safety of three doses of botulinum toxin type A with placebo in upper limb

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. Secondary progressive eficacy clinical trial

This was a randomized, double-blind, multicenter (four centers), phase III, parallel clinical trial conducted in Brazil and comparing the efficacy and safety of a fixed-dose,

The pentamidine is one of drugs for treatment of leishmaniasis and it is used in cutaneous, diffuse- cutaneous and mucocutaneous leishmaniasis and in visceral

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of

Moreover, and in particular in this study, a secreted protein acidic and rich in cysteine (SPARC) has been added to the porous matrix based on collagen type I, nanoparticles of HA

Safety and efficacy of fingolimod in patients with relapsing- remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial. Polman